Efficacy and acceptability of psychological interventions for social anxiety disorder in children and adolescents: a meta-analysis of randomized controlled trials.


Journal

European child & adolescent psychiatry
ISSN: 1435-165X
Titre abrégé: Eur Child Adolesc Psychiatry
Pays: Germany
ID NLM: 9212296

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 16 01 2018
accepted: 28 06 2018
pubmed: 15 7 2018
medline: 21 3 2019
entrez: 15 7 2018
Statut: ppublish

Résumé

Social anxiety disorder (SAD) is highly prevalent and persistent in children and adolescents. However, evidence for the efficacy and acceptability of psychological interventions for SAD in children and adolescents remains unclear. Seven electronic databases (PubMed, CENTRAL, Embase, Web of Science, PsycINFO, CINAHL, and ProQuest) were searched. Randomized controlled trials (RCTs) that compared psychological interventions for SAD with control conditions in children and adolescents were included. Primary outcomes were the efficacy (mean change in anxiety symptom scores) and acceptability (dropouts for all reasons). Secondary outcomes were remission, quality of life/functional improvement, and depressive symptoms measures. Seventeen RCTs were included in this meta-analysis. Psychological interventions (including cognitive behavioral therapy and behavioral therapy) were significantly more effective than control conditions, with a standardized mean difference (SMD) of - 1.13, and remission with a risk ratio (RR) of 8.99, the number needed to treat was 3.3. There was no statistically significant difference between psychological interventions and control conditions for all-cause dropouts (RR = 1.00). Psychological interventions were superior to control conditions in improving quality of life/functioning (SMD = 0.79) and reducing depressive symptoms (SMD = - 0.39). Given considerable heterogeneity of primary efficacy outcome, a series of subgroup analyses of different variables were conducted. Psychological interventions are probably efficacious in the treatment of SAD among children and adolescents, and may markedly improve quality of life and functioning in this population. However, this finding should be interpreted with caution because of the high heterogeneity of trials and low literature quality.

Identifiants

pubmed: 30006672
doi: 10.1007/s00787-018-1189-x
pii: 10.1007/s00787-018-1189-x
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-89

Références

J Am Acad Child Adolesc Psychiatry. 2000 Jun;39(6):721-6
pubmed: 10846306
Psychiatry Investig. 2016 Sep;13(5):574-576
pubmed: 27757138
J Clin Child Psychol. 1998 Dec;27(4):459-68
pubmed: 9866083
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
J Child Psychol Psychiatry. 2000 Sep;41(6):713-26
pubmed: 11039684
BMC Psychiatry. 2016 Jul 19;16:248
pubmed: 27431392
J Am Acad Child Adolesc Psychiatry. 2011 Sep;50(9):870-80
pubmed: 21871369
BMC Psychiatry. 2011 Dec 20;11:200
pubmed: 22185596
Psychol Med. 1999 Mar;29(2):309-23
pubmed: 10218923
J Anxiety Disord. 2016 Aug;42:105-12
pubmed: 27399932
J Anxiety Disord. 2016 Apr;39:44-64
pubmed: 26953823
Psychopathology. 2016;49(2):95-107
pubmed: 27089281
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Can J Psychiatry. 2013 Jul;58(7):376-85
pubmed: 23870719
Cochrane Database Syst Rev. 2015 Feb 18;(2):CD004690
pubmed: 25692403
Emotion. 2016 Jun;16(4):475-487
pubmed: 26641271
Am Psychol. 2017 Feb-Mar;72(2):79-117
pubmed: 28221063
Arch Gen Psychiatry. 1994 Dec;51(12):975-83
pubmed: 7979886
Behav Res Ther. 2015 Apr;67:19-29
pubmed: 25727679
J Abnorm Child Psychol. 2005 Dec;33(6):707-22
pubmed: 16328746
J Child Psychol Psychiatry. 2016 Nov;57(11):1229-1238
pubmed: 27002215
Psychother Psychosom. 2014;83(1):54-61
pubmed: 24281563
Behav Res Ther. 2017 Mar;90:41-57
pubmed: 27988427
J Abnorm Child Psychol. 1996 Apr;24(2):187-203
pubmed: 8743244
J Consult Clin Psychol. 2000 Dec;68(6):1072-80
pubmed: 11142541
Int J Neuropsychopharmacol. 2001 Sep;4(3):279-98
pubmed: 11602035
J Abnorm Psychol. 1997 May;106(2):280-97
pubmed: 9131848
J Child Psychol Psychiatry. 2007 Jul;48(7):676-86
pubmed: 17593148
World Psychiatry. 2015 Jun;14(2):207-22
pubmed: 26043339
Child Adolesc Psychiatry Ment Health. 2009 Nov 11;3(1):36
pubmed: 19906313
Lancet. 2016 Aug 27;388(10047):881-90
pubmed: 27289172
Psychol Med. 2016 Dec;46(16):3451-3462
pubmed: 27659840
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
J Am Acad Child Adolesc Psychiatry. 2005 Mar;44(3):258-64
pubmed: 15725970
J Abnorm Child Psychol. 1998 Apr;26(2):83-94
pubmed: 9634131
Lancet Psychiatry. 2014 Oct;1(5):368-76
pubmed: 26361000
Curr Psychiatry Rep. 2016 Mar;18(3):25
pubmed: 26830883
BMJ. 2011 Feb 10;342:d549
pubmed: 21310794
Psicothema. 2014;26(4):483-9
pubmed: 25340895
Child Adolesc Psychiatry Ment Health. 2011 Feb 28;5(1):5
pubmed: 21356037
Cogn Behav Ther. 2011;40(2):147-57
pubmed: 25155815
J Anxiety Disord. 2009 Mar;23(2):167-77
pubmed: 18653310
Am J Psychiatry. 2001 Dec;158(12):1999-2007
pubmed: 11729016
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Lining Yang (L)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Xinyu Zhou (X)

Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.

Juncai Pu (J)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Lanxiang Liu (L)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Pim Cuijpers (P)

Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands. p.cuijpers@vu.nl.

Yuqing Zhang (Y)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Hanping Zhang (H)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Shuai Yuan (S)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Teng Teng (T)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Lu Tian (L)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China.

Peng Xie (P)

Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Yixueyuan Road, Yuzhong District, Chongqing, 400016, People's Republic of China. xiepeng973@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH